(19)
(11) EP 1 758 989 A2

(12)

(88) Date of publication A3:
02.03.2006

(43) Date of publication:
07.03.2007 Bulletin 2007/10

(21) Application number: 05723204.3

(22) Date of filing: 16.02.2005
(51) International Patent Classification (IPC): 
C12N 5/16(2006.01)
A61K 35/12(2006.01)
C12N 5/22(2006.01)
(86) International application number:
PCT/US2005/005052
(87) International publication number:
WO 2005/123123 (29.12.2005 Gazette 2005/52)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 08.06.2004 US 864788
15.07.2004 US 588146 P

(71) Applicant: PrimeGen Biotech LLC
Irvine, CA 92618 (US)

(72) Inventors:
  • SAYRE, Chauncey, B.
    Irvine, CA 92606 (US)
  • SILVA, Francisco, J.
    Rancho Cucamonga, CA 91730 (US)

(74) Representative: Green, Mark Charles 
Urquhart-Dykes & Lord LLP 30 Welbeck Street
London W1G 8ER
London W1G 8ER (GB)

   


(54) THERAPEUTIC REPROGRAMMING, HYBRID STEM CELLS AND MATURATION